SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X is trending as a Bitcoin-native meme coin launched via the Runes protocol, generating buzz for its fair distribution and strong community. Discussions highlight its potential to drive utility and transaction volume on the Bitcoin network, with many touting it as a leader in the current cycle. Community members are actively promoting its unique position compared to other meme coins and speculating about potential exchange listings.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending amid speculation around a potential licensing deal with AstraZeneca, with community members discussing the impact of recent trial data and a possible buyout. Some investors are analyzing trial endpoints and revenue potential, while others are comparing SMMT to competitors like IOVA. The community is closely watching for further developments and official announcements.

ProShares Trust - ProShares Short Dow30 -1x Shares

ProShares Short Dow30

ProShares Short Dow30 ($DOG) is trending as community members highlight its potential as the 'meme face of Bitcoin'. Many view $DOG as more than just a memecoin, emphasizing its fair launch, community ownership, and listing on major crypto exchanges. The 'cult-like army' backing the coin and its potential to mirror $SHIB's success on ETH are also driving interest.

DOVU

DOVU.X is trending as the community highlights its staking rewards and potential in the Real World Asset (RWA) space, particularly due to its "Trust Operating System." Recent news around partnerships and deals related to carbon credits and ecological projects may be acting as a catalyst. Community members are actively discussing its association with Hedera and potential for significant growth.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending due to a significant land sale agreement, potentially boosting its NAV. The community is discussing the stock's low float and potential for a substantial price increase, with some highlighting potential squeeze dynamics. Bullish sentiment appears to be building, driven by the company's real estate assets and upcoming shareholder meeting.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

$BROKE.X is trending amid community excitement around staking application launch and ongoing buy contests. The community buzzes about the coin's strong performance relative to $SOL.X and anticipates further burns as watcher numbers climb. Enthusiastic community members highlight the project's doxxed developers and active engagement.

The Children's Place, Inc. engages in the provision of apparel, footwear, accessories, and other items for children. The firm also designs contracts to manufacture and sell fashionable and value-priced merchandise under the brand names of The Children’s Place, Baby Place, and Gymboree. It operates through The Children’s Place U.S. and The Children’s Place International segments. The Children’s Place U.S. segment refers to the company’s U.S. and Puerto Rico-based stores and revenue from its U.S. based wholesale business. The Children’s Place International segment is involved in the Canadian-based stores, revenue from the company’s Canadian-based wholesale business, as well as revenue from international franchisees. The company was founded by David Pulver and Clinton A. Clark in 1969 and is headquartered in Secaucus, NJ.

Childrens Place Inc

Children's Place is trending due to recent earnings and guidance, with discussions centered on a potential short squeeze given its high short interest. Community members are debating the company's turnaround efforts and the impact of new management, with some highlighting positive comparable DTC sales and others expressing concerns about financials and potential bankruptcy. The stock's low float and high short interest are fueling speculation about a significant price movement.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

ABBV is trending as community members discuss its potential moves in the psychedelic drug space following a recent acquisition, with some suggesting further buyouts of companies like ATAI and CYBN. Also under discussion is AbbVie's oncology pipeline, particularly the potential acquisition of $SLS, driven by promising GPS immunotherapy data. Bullish sentiment is further fueled by updated ratings and price targets from analysts.

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. It focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

Ideaya Biosciences Inc

IDYA is trending due to positive Phase 2 trial data for their uveal melanoma treatment, darovasertib, and a successful FDA meeting, leading to potential accelerated approval. The community is optimistic about the drug's potential and the company's pipeline, with some analysts increasing price targets. Broader interest is fueled by the company's strategic advancements in precision oncology and synthetic lethality.

Voyager Technologies, Inc. engages in the defense technology and space solutions. It operates through the following segments: Defense & National Security, Space Solutions, and Starlab Space Stations. The Defense & National Security segment consists of innovative mission-critical solutions to protect dynamic and contested domains. The Space Solutions segment consists of space infrastructure, advanced space technology, science systems and mission services. The Starlab Space Stations segment consists of a commercial space station. The company was founded by Dylan Taylor and Matthew Kuta on August 15, 2019 and is headquartered in Denver, CO.

Voyager Technologies Inc. - Ordinary Shares - Class A

Voyager Technologies Inc

VOYG is trending as investors are digesting the implications of its recent inclusion in the Russell 2000 Index and various analyst ratings. The community is actively discussing the company's potential in the defense and space sectors, particularly its connections to initiatives like Golden Dome and partnerships with companies like Palantir. While some see long-term potential, others express concerns about the stock's performance since its IPO and its current valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Colony Bankcorp (CBAN) Q2 Earnings and Revenues Surpass Estimates

Colony Bankcorp (CBAN) delivered earnings and revenue surprises of +15.00% and +4.68%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

New Strong Sell Stocks for July 2nd

COLD, CBAN and DDI have been added to the Zacks Rank #5 (Strong Sell) List on July 2, 2025.

Are Options Traders Betting on a Big Move in Colony Bankcorp Stock?

Colony Bankcorp, Inc. to Participate in Janney Annual CEO Forum

Colony Bankcorp, Inc. (NYSE: CBAN) (Colony or the Company) announced today that Heath Fountain, Chief Executive Officer, and Derek Shelnutt, Chief Financial Officer, will participate in the Janney...

Colony Bankcorp Reports Fourth Quarter 2024 Results

Colony Bankcorp, Inc. (NYSE: CBAN) (Colony or the Company) today reported financial results for the fourth quarter of 2024. Financial highlights are shown below. Financial Highlights: Net income...

Colony Bankcorp, Inc. Strengthens Leadership Team With Executive Promotions and Organizational Enhancements

Colony Bankcorp, Inc. (NYSE: CBAN) (Colony or the Company) is pleased to announce the promotion of three seasoned leaders, Ed Canup, Daniel Rentz, and Laurie Senn, to Executive Vice President roles...

Colony Bankcorp, Inc. Announces Date for Fourth Quarter 2024 Earnings Release and Conference Call

Colony Bankcorp, Inc. (NYSE: CBAN) (Colony or the Company) today announced that it will release its fourth quarter 2024 financial results on Wednesday, January 22, 2025, after the stock market...

Colony Bankcorp, Inc. to Participate in 2024 Hovde Group Financial Services Conference

Colony Bankcorp, Inc. (Nasdaq: CBAN) (Colony or the Company) announced today that Heath Fountain, Chief Executive Officer, and Derek Shelnutt, Chief Financial Officer, will participate in the 2024...

Colony Bankcorp, Inc. Announces Transfer of Listing of Common Stock to the New York Stock Exchange

Colony Bankcorp, Inc. (Nasdaq: CBAN) (Colony or the Company) the parent company of Colony Bank, announced today that it is transferring the listing of its common stock to the New York Stock Exchange...

Colony Bankcorp Reports Third Quarter 2024 Results

Colony Bankcorp, Inc. (Nasdaq: CBAN) (Colony or the Company) today reported financial results for the third quarter of 2024. Financial highlights are shown below. Financial Highlights: Net income...

Colony Bankcorp, Inc. is a bank holding company, which engages in the stockholder and investor relations functions through its subsidiary, Colony Bank. It operates through the following segments: Banking Division, Mortgage Division, and Small Business Specialty Lending Division. The Banking Division segment offers full service financial services including commercial loans, consumer loans and deposit accounts. The Mortgage Division segment consists of sales and servicing of one-to-four family residential mortgage loans. The Small Business Specialty Lending Division segment focuses on the selling and servicing of SBA and USDA government guaranteed loans. The company was founded on November 8, 1982 and is headquartered in Fitzgerald, GA.

Current Price	$17.10
Prev Close	$17.44
Open	$17.48
Dividend Yield	2.79%
50-Day Moving Average	$16.90
Beta	0.79
Avg. Volume	57,029.86
PE Ratio	10.83

52-Week High	$18.49
52-Week Low	$13.99
Market Capitalization	$298.59M
EPS (Annual)	$1.36
Price to Book	1.01
Revenue Per Employee	$380,182.80
Enterprise Value/EBITDA	N/A

CBAN
Colony Bankcorp, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CBAN News

CBAN Colony Bankcorp, Inc.